These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34820750)

  • 1. Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review.
    Wilson S; Milanini B; Javandel S; Nyamayaro P; Valcour V
    Curr HIV/AIDS Rep; 2021 Dec; 18(6):581-592. PubMed ID: 34820750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.
    Yechoor N; Towe SL; Robertson KR; Westreich D; Nakasujja N; Meade CS
    J Neurovirol; 2016 Dec; 22(6):808-815. PubMed ID: 27245592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings.
    Chan LG; Ho MJ; Lin YC; Ong Y; Wong CS
    AIDS Res Ther; 2019 Apr; 16(1):9. PubMed ID: 30987670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guide.
    Kamminga J; Cysique LA; Lu G; Batchelor J; Brew BJ
    Curr HIV/AIDS Rep; 2013 Dec; 10(4):342-55. PubMed ID: 24072534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use.
    Kamminga J; Lal L; Wright EJ; Bloch M; Brew BJ; Cysique LA
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):83-92. PubMed ID: 28284004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.
    Wojcik CM; Beier M; Costello K; DeLuca J; Feinstein A; Goverover Y; Gudesblatt M; Jaworski M; Kalb R; Kostich L; LaRocca NG; Rodgers JD; Benedict RH;
    Mult Scler; 2019 Dec; 25(14):1848-1869. PubMed ID: 31637963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.
    Anderson AM; Lennox JL; Nguyen ML; Waldrop-Valverde D; Tyor WR; Loring DW
    J Neurovirol; 2016 Dec; 22(6):816-822. PubMed ID: 27245594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.
    Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A
    AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological soft signs (NSS) and cognitive deficits in HIV associated neurocognitive disorder.
    Forno G; Henríquez F; Ceballos ME; Gonzalez M; Schröder J; Toro P
    Neuropsychologia; 2020 Sep; 146():107545. PubMed ID: 32593722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder.
    Rosenthal LS; Skolasky RL; Moxley RT; Roosa HV; Selnes OA; Eschman A; McArthur JC; Sacktor N
    J Neurovirol; 2013 Oct; 19(5):432-41. PubMed ID: 24081883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.
    Robbins RN; Scott TM; Gouse H; Marcotte TD; Rourke SB
    Curr Top Behav Neurosci; 2021; 50():429-478. PubMed ID: 32677005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Validity of a Computerized Battery for Identifying Neurocognitive Impairments Among Children Living with HIV in Botswana.
    Van Pelt AE; Moore TM; Scott JC; Phoi O; Mbakile-Mahlanza L; Morales KH; Gur RC; Rampa S; Matshaba M; Lowenthal ED
    AIDS Behav; 2022 Aug; 26(8):2758-2767. PubMed ID: 35182282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Evaluation of an Abbreviated Test Battery to Screen for Neurocognitive Impairment in HIV-Positive Military Members.
    Agan BK; Won SH; Ganesan A; Smith BR; Estupigan C; Maves R; Utz G; Hsieh HC; Tramont E; Nath A; Snow J
    AIDS Behav; 2021 Oct; 25(10):3347-3354. PubMed ID: 34382119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living With Human Immunodeficiency Virus and a Proposed Way Forward.
    Nightingale S; Dreyer AJ; Saylor D; Gisslén M; Winston A; Joska JA
    Clin Infect Dis; 2021 Sep; 73(6):1113-1118. PubMed ID: 33904889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Screening Tests Versus Comprehensive Neuropsychological Test Batteries: A National Academy of Neuropsychology Education Paper†.
    Roebuck-Spencer TM; Glen T; Puente AE; Denney RL; Ruff RM; Hostetter G; Bianchini KJ
    Arch Clin Neuropsychol; 2017 Jun; 32(4):491-498. PubMed ID: 28334244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of brain network topology in HIV-associated neurocognitive disorder: A novel functional connectivity perspective.
    Abidin AZ; DSouza AM; Nagarajan MB; Wang L; Qiu X; Schifitto G; Wismüller A
    Neuroimage Clin; 2018; 17():768-777. PubMed ID: 29527484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.